Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661726 · ClinicalTrials.gov registry record · Phase 2
Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia
A Phase 2 study, sponsored by Carelon Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00661726: Completed Phase 2 study, sponsored by Carelon Research.
NCT00661726 is a Phase 2 study that has completed, run by Carelon Research. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00661726, a Phase 2 study, has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
Thalassemia intermedia (TI) is an inherited blood disorder that can cause anemia due to low levels of hemoglobin. Decitabine is a medication that may be effective at increasing hemoglobin levels. This study will evaluate the safety and effectiveness of decitabine at increasing hemoglobin levels in people with TI.
Interventions
- DRUG Decitabine (USAN, INN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
What the finished NCT00661726 record still lists
NCT00661726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Decitabine (USAN, INN) is the first listed.
NCT00661726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00661726 about?
NCT00661726 is a clinical study titled "Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia". Thalassemia intermedia (TI) is an inherited blood disorder that can cause anemia due to low levels of hemoglobin. Decitabine is a medication that may be effective at increasing hemoglobin levels. This study will evaluate the safety and effectiveness of decitabine at increasing hemoglobin levels in p...
What is the current status of trial NCT00661726?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2008-01. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00661726?
The interventions under investigation include: Decitabine (USAN, INN) (DRUG).
Who is sponsoring clinical trial NCT00661726?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00661726's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia